Wednesday, June 25, 2025

Deep 6 AI and Graticule Partner to Accelerate Clinical Trial Recruitment and Improve Population Health

Related stories

Digital Science launches AI writing tools for Overleaf users

Digital Science announced the launch of AI Assist, an...

Centific and Virtue AI team up on responsible AI by Design

This integration delivers 30x faster multimodal protection enabling full-stack...

Vultr Gets $329M to Expand Global AI and Cloud Platform

Vultr secures $329M in credit financing to boost global...

Okta Adds Cross App Access to Secure enterprise AI Agents

Okta launches Cross App Access, a new OAuth-based protocol...

SWARM Biotactics Raises €13M to Advance Bio-Robotics

SWARM Biotactics, developer of bio-robotic systems based on fully...
spot_imgspot_img

Deep 6 AI, a leading AI-powered precision research platform for healthcare organizations and life sciences companies, announced its partnership with Graticule, an on-demand, advanced real-world data and advisory services provider. The two companies are designing research algorithms and real-world data services to better identify and prioritize patients for clinical trials across many disease indications. Their first algorithm automates patient screening for a sponsored cardiovascular medical device trial. This time-saving technology, coupled with rapid implementation services, is being actively piloted at sites in the Deep 6 AI research ecosystem to accelerate trial completion.

Key measurements indicating a patient’s eligibility for the clinical trial or qualification for standard of care treatment, such as the measure of the heart’s ejection fraction, did not exist within structured electronic medical record (EMR) data. The solution developed by Deep 6 AI and Graticule uses artificial intelligence (AI) and natural language processing (NLP) to mine large, real-time pools of structured and unstructured electronic medical record (EMR) data, such as clinical notes, radiology reports, and catheterization lab reports, to precisely identify a cohort of eligible patients and extract key insights into each patient’s condition and history. The screening algorithm then uses these insights to qualify and prioritize eligible patients to provide a clearer picture of the patients most likely to benefit from the intervention. The extracted, relevant information is presented to the research team in useful and intuitive ways.

Also Read: Virtual Science AI unveils an industry-first therapeutic area landscape analysis solution for life science…

“Traditionally, it takes up to two years for life sciences companies to get access to EMR data to develop novel patient matching algorithms,” said Dan Housman, Chief Technology Officer, Graticule. “Additionally, traditional methods of ‘clinical data pulling’ often burden an already overworked hospital IT staff. We partnered with Deep 6 AI to accelerate the development and deployment of screening tools that reduce site burden through access to ready to use deep EMR data from 1K+ research facilities across the Deep 6 AI ecosystem.”

“We help clinical research teams identify targeted patient populations with great precision and speed by using AI to mine deeper data that goes beyond traditional claims and structured EMR data,” said Wout Brusselaers, founder and CEO, Deep 6 AI. “By applying Graticule’s real-world data research methods and advisory services to the real-time, real patient data within our research ecosystem, we have drastically improved the utility of the research algorithms and screening processes we offer.”

SOURCE: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img